PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Hepatitis B virus reemerges with long-term nucleoside analog treatment

Virological breakthrough not linked to antiviral drug resistance; non-adherence to medication likely

2011-04-28
(Press-News.org) A recently published study revealed that virological breakthrough (VBT) is common in patients receiving nucleoside analogs (NUCs) for chronic hepatitis B. Nearly 40% of the VBTs found were not related to antiviral drug resistance. Details of this retrospective study are published in the May issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.

VBT is the first manifestation of antiviral drug resistance during NUC therapy of chronic hepatitis B. NUC drugs approved for treatment of chronic hepatitis B include lamivudine (LAM), adefovir (ADV), entecavir (ETV), telbivudine (TBV), and tenofovir (TDF). While the medications suppress the virus with few side effects, they do not eradicate HBV and require long-term treatment to provide clinical benefit. With long-term NUC therapy, studies have shown an increasing risk of drug resistance particularly with monotherapy regimens.

In the current study, Anna Lok, M.D. and colleagues from the University of Michigan Health System examined the incidence of VBT and genotypic resistance (GR) in 148 patients with chronic hepatitis B who were treated with NUCs between January 2000 and July 2010. The mean age of study participants was 45 years and 73% were male. Researchers reviewed medical records and recorded patient demographics, hepatitis B virus (HBV) markers, liver panel, blood counts and liver histology.

Results showed that during a mean follow-up of 38 months, 39 (26%) patients had at least one VBT, and upon retesting, 15 (38%) of these patients did not have a VBT and 10 had no evidence of GR. Researchers reported the probability of VBT, confirmed VBT, and GR at five years was 46%, 30%, and 34%, respectively. "Our analysis showed an alarmingly high rate of VBT in clinical practice and the only factor significantly linked to VBT was failure to achieve undectectable HBV DNA," said Dr. Lok.

HBV DNA decreased in the ten patients who initially experienced a VBT, but who did not have confirmed VBT or GR, when the same drug regimen was maintained. Nine of these patients had undetectable HBV DNA at the most recent follow-up, a mean of 7 months after the initial VBT. These data suggest that nonadherence to medication may be a common cause of VBT. "Counseling patients with chronic hepatitis B on the importance of medication adherence, and confirming reemergence of the virus and genetic mutations that cause resistance, can help to avoid unnecessary changes to antiviral treatments," advised Dr. Lok.

INFORMATION:

Article: "Virological Breakthrough and Resistance in Patients with Chronic Hepatitis B Receiving Nucleos(t)ide Analogs in Clinical Practice." Chanunta Hongthanakorn, Watcharasak Chotiyaputta, Kelly Oberhelman, Robert J. Fontana, Jorge A. Marrero, Tracy Licari and Anna S.F. Lok. Hepatology; Published Online: March 24, 2011 (DOI: 10.1002/hep.24318); Print Issue Date: May 2011. http://onlinelibrary.wiley.com/doi/10.1002/hep.24318/abstract.

This study is published in Hepatology. Media wishing to receive a PDF of the articles may contact healthnews@wiley.com.

About the Journal

Hepatology is the premier publication in the field of liver disease, publishing original, peer-reviewed articles concerning all aspects of liver structure, function and disease. Each month, the distinguished Editorial Board monitors and selects only the best articles on subjects such as immunology, chronic hepatitis, viral hepatitis, cirrhosis, genetic and metabolic liver diseases and their complications, liver cancer, and drug metabolism. Hepatology is published on behalf of the American Association for the Study of Liver Diseases (AASLD). For more information, please visit http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1527-3350 .

About Wiley-Blackwell

Wiley-Blackwell is the international scientific, technical, medical, and scholarly publishing business of John Wiley & Sons, with strengths in every major academic and professional field and partnerships with many of the world's leading societies. Wiley-Blackwell publishes nearly 1,500 peer-reviewed journals and 1,500+ new books annually in print and online, as well as databases, major reference works and laboratory protocols. For more information, please visit www.wileyblackwell.com or our new online platform, Wiley Online Library (wileyonlinelibrary.com), one of the world's most extensive multidisciplinary collections of online resources, covering life, health, social and physical sciences, and humanities.

END



ELSE PRESS RELEASES FROM THIS DATE:

2 graphene layers may be better than 1

2 graphene layers may be better than 1
2011-04-28
Researchers at the National Institute of Standards and Technology (NIST) have shown that the electronic properties of two layers of graphene vary on the nanometer scale. The surprising new results reveal that not only does the difference in the strength of the electric charges between the two layers vary across the layers, but they also actually reverse in sign to create randomly distributed puddles of alternating positive and negative charges. Reported in Nature Physics,* the new measurements bring graphene a step closer to being used in practical electronic devices. Graphene, ...

Illinois Drugged Driving Law: Unbending and Complex

2011-04-28
Illinois Drugged Driving Law: Unbending and Complex Illinois law is tough on anyone caught behind the wheel under the influence of drugs to the point that he or she cannot safely drive. And it is not a defense that the drug was legal for the individual to use. A Rising Trend? According to the federal government, the percentage of fatally injured drivers with drugs in their systems is on the rise nationally. The National Highway Transportation Safety Administration, part of the U.S. Department of Transportation, announced in November 2010 the results of an important ...

Dunwoody Hotel Near Atlanta Announces the New Perimeter Dining Card Package

Dunwoody Hotel Near Atlanta Announces the New Perimeter Dining Card Package
2011-04-28
The Holiday Inn Express & Suites Atlanta Perimeter Hotel (North) near Perimeter Mall announces the Perimeter Dining Card Package. Available for a limited time, guests who book this package will receive a $25 Perimeter Passion Dining Card (must have a minimum $50 purchase). Only one certificate can be used per table and does not include alcoholic beverages, gratuity or tax. Some restrictions and blackout dates may apply. Perimeter Passion Dining Card restaurants include: - Wildfire - McKendricks - Ruth's Chris Steak House - Nancy G's Cafe - Sage Woodfire Tavern ...

NIST prototypes framework for evaluating sustainability standards

2011-04-28
As manufacturers and other businesses step up efforts to cut waste, reduce energy use and improve the overall sustainability of their products and processes, the number of planet-friendly standards and regulations also is increasing at a rapid clip, creating a sometimes-confusing array of options for "going green." National Institute of Standards and Technology (NIST) researchers have prototyped a framework to help organizations of all types sort through the welter of choices and evaluate and implement sustainability standards most appropriate for their operations and interests. The ...

Tobacco-derived compound prevents memory loss in Alzheimer's disease mice

Tobacco-derived compound prevents memory loss in Alzheimers disease mice
2011-04-28
Tampa, FL (For immediate release) -- Cotinine, a compound derived from tobacco, reduced plaques associated with dementia and prevented memory loss in a mouse model of Alzheimer's disease, a study led by researchers at Bay Pines VA Healthcare System and the University of South Florida found. The findings are reported online in the Journal of Alzheimer's Disease in advance of print publication. "We found a compound that protects neurons, prevents the progression of Alzheimer's disease pathology, enhances memory and has been shown to be safe," said Valentina Echeverria, ...

Atlanta Orthopedic Doctor Peter Symbas Named Official Physician for Atlanta Silverbacks

Atlanta Orthopedic Doctor Peter Symbas Named Official Physician for Atlanta Silverbacks
2011-04-28
Peter Symbas, an Atlanta orthopedic doctor with Southern Orthopaedic Specialists, was recently named the Official Sports Medicine Provider and Team Physician for the Atlanta Silverbacks, an Atlanta soccer organization. Southern Orthopaedics Specialists, an official partner of the Silverbacks, is a full service Atlanta orthopedics practice specializing in orthopedic surgery and sports medicine. Dr. Symbas, an Atlanta native, has a relevant background in soccer, experience that will be valuable as his work as an Atlanta orthopedic doctor for the Silverbacks. Symbas was ...

Severity of hepatitis C and HIV co-infection in mothers contribute to HCV transmission to child

2011-04-28
New research shows that high maternal viral load and co-infection with human immunodeficiency virus (HIV) are the only risk factors associated with vertical transmission of the hepatitis C virus (HCV-VT). A variation in the infant's IL28B gene (CC) is associated independently with the spontaneous clearance of HCV genotype-1 among infected children. The status of IL28B in the mother or children did not increase risk of HCV-VT in this study. Findings are published in the May issue of Hepatology, a peer-reviewed journal of the American Association for the Study of Liver Diseases. ...

Long struggle for appropriately processed manufacturer data leads to a new assessment of memantine

2011-04-28
After the manufacturer of the Alzheimer's drug memantine submitted a supplementary analysis of study data, the German Institute for Quality and Efficiency in Health Care (IQWiG) sees proof of a benefit of the drug for cognitive function, as well as indications of a benefit for activities of daily living, at least for a treatment period of 6 months. This changes the conclusions of the first IQWiG benefit assessment of 2009. IQWiG had repeatedly called upon the manufacturer Merz to provide a renewed analysis of study data appropriate to the research question. Additional ...

Andromeda's coat of many colors

2011-04-28
VIDEO: ESA's fleet of space telescopes has captured the nearby Andromeda Galaxy, also known as M31, in different wavelengths. Most of these wavelengths are invisible to the eye and each shows... Click here for more information. ESA's fleet of space telescopes has captured the nearby Andromeda Galaxy, also known as M31, in different wavelengths. Most of these wavelengths are invisible to the eye and each shows a different aspect of the galaxy's nature. Visible light, as seen ...

Atlanta Pool Service Company Piranha Pool Management Highlights Key Steps For Summer Pool Preparation

Atlanta Pool Service Company Piranha Pool Management Highlights Key Steps For Summer Pool Preparation
2011-04-28
Atlanta pool service company Piranha Pool Management is recommending that homeowners in the Atlanta area properly prepare their pools for renewed use in the coming months. After going unused with minimal maintenance in the winter, pool preparation is essential before summertime. Piranha Pool Management provides comprehensive Atlanta pool maintenance and repair, including a summer start-up service. In temperate cities like Atlanta, pools are strongly affected by the change in seasons. In the fall, they are covered to keep out the falling leaves and dropping temperatures, ...

LAST 30 PRESS RELEASES:

Science briefing: An update on GLP-1 drugs for obesity

Lower doses of immunotherapy for skin cancer give better results

Why didn’t the senior citizen cross the road? Slower crossings may help people with reduced mobility

ASH 2025: Study suggests that a virtual program focusing on diet and exercise can help reduce side effects of lymphoma treatment

A sound defense: Noisy pupae puff away potential predators

Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukemia patients eligible for intensive chemotherapy

Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes

New findings support a chemo-free approach for treating Ph+ ALL

Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

Dose of psilocybin, dash of rabies point to treatment for depression

Helping health care providers navigate social, political, and legal barriers to patient care

[Press-News.org] Hepatitis B virus reemerges with long-term nucleoside analog treatment
Virological breakthrough not linked to antiviral drug resistance; non-adherence to medication likely